When all dose groups were combined, 128 56 showed at least 50 reduction from baseline in the number of wet nights weeks, while 87 38 patients achieved complete or near complete ddavp meksiko response. The DDAVP only treats the symptoms and when they stop taking it, bedwetting may return. Most health care professionals recommend that after period of 1-2 months, the dose of DDAVP should be slowly decreased. Single study in postpartum women demonstrated marked change in plasma, but little if any change in assayable DDAVP in breast milk following an intranasal dose of 10 mcg. Hemarthrosis hemorrhages in the joints causing pain, swelling and limited movement. Previous next Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA.